3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
HhAntag691
14
sonidegib
4
methyl 5-aminolevulinate
3
Photochemotherapy
3
Aminolevulinic Acid
3
tazarotene
2
cemiplimab
2
IPI-926
2
Drug Evaluation
2
1-phenyl-3,3-dimethyltriazene
2
silmitasertib
1
remetinostat
1
prednylidene
1
pembrolizumab
1
deltacortene
1
Tacrolimus
1
Risk Factors
1
Prednisone
1
Nivolumab
1
NVP-BKM120
1
Mohs Surgery
1
Mindfulness
1
Midazolam
1
Itraconazole
1
Ipilimumab
1
IFL protocol
1
Folfox protocol
1
Fluorouracil
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Basal Cell
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.